News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
REARDON WILLIAM S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on Tekla Healthcare Opportunities Fund|
Txns:
| Bought 1,196 shares of beneficial interest
@ $20.85, valued at
$24.9k
|
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $1.53, valued at
$76.5k
|
|
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $1.63, valued at
$81.5k
|
|
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2016 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options to buy
@ $1.44, valued at
$50.4k
|
|
| 07/06/2015 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Granted 5,681 shares
@ $0
Granted 2,272 shares
@ $0
Granted 20,000 options to buy
@ $2.2, valued at
$44k
|
|
| 06/10/2015 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options
@ $3.59, valued at
$125.7k
|
|
| 07/03/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 2,363 shares
@ $2.83, valued at
$6.7k
|
|
| 07/03/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Granted 4,878 shares
@ $0
Granted 10,000 options to buy
@ $4.1, valued at
$41k
|
|
| 07/01/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on H&Q LIFE SCIENCES INVESTORS|
Txns:
| Bought 200 shares of beneficial interest
@ $19.75, valued at
$4k
|
|
| 06/30/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on H&Q LIFE SCIENCES INVESTORS|
Txns:
| Exercised (in-or-at-the-money) 1,134 rights
@ $19.75, valued at
$22.4k
|
|
| 06/30/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on H&Q HEALTHCARE INVESTORS|
Txns:
| Exercised (in-or-at-the-money) 1,226 rights
@ $25.037, valued at
$30.7k
|
|
| 06/11/2014 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options
@ $3.25, valued at
$113.8k
|
|
| 11/15/2013 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Bought 13,333 shares
@ $3.75, valued at
$50k
|
|
| 09/17/2013 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 13,561 shares
@ $1.8172, valued at
$24.6k
|
|
| 08/16/2013 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options
@ $1.5, valued at
$60k
|
|
| 07/30/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2012 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options
@ $0.91, valued at
$18.2k
|
|
| 03/12/2012 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on H&Q HEALTHCARE INVESTORS|
Txns:
| Bought 646 shares of beneficial interest
@ $15.8551, valued at
$10.2k
Bought 646 shares of beneficial interest
@ $15.8551, valued at
$10.2k
|
|
| 03/12/2012 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on H&Q LIFE SCIENCES INVESTORS|
Txns:
| Bought 772 shares of beneficial interest
@ $13.266, valued at
$10.2k
|
|
| 07/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/18/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2009 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP |
| 06/16/2009 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC. |
| 04/03/2009 |
4
| REARDON WILLIAM S (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC. |
|
|